The Endothelial GLP-1 Receptor is Critical for the Cardiovascular Protective Effects of GLP-1 (Liraglutide) Treatment in Experimental Arterial Hypertension

被引：0
|
作者：
Helmstadter, Johanna
Filippou, Konstantina
Pawelke, Franziska
Frenis, Katie
Vujacic-Mirski, Ksenija
Kalinovic, Sanela
Kroller-Schon, Swenja
Oelze, Matthias
Munzel, Thomas
Daiber, Andreas
Steven, Sebastian
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A412
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cardiovascular benefits of GLP-1 (liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor
    Steven, S.
    Helmstaedter, J.
    Filippou, K.
    Pawelke, F.
    Katie, F.
    Vujacic-Mirski, K.
    Kalinovic, S. S.
    Kroeller-Schoen, S.
    Oelze, M.
    Munzel, T.
    Daiber, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2699 - 2699
  • [2] Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
    Helmstaedter, Johanna
    Frenis, Katie
    Filippou, Konstantina
    Grill, Alexandra
    Dib, Mobin
    Kalinovic, Sanela
    Pawelke, Franziska
    Kus, Kamil
    Kroeller-Schoen, Swenja
    Oelze, Matthias
    Chlopicki, Stefan
    Schuppan, Detlef
    Wenzel, Philip
    Ruf, Wolfram
    Drucker, Daniel J.
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (01) : 145 - 158
  • [3] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [4] Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
    Vandemark, Collin
    Nguyen, Jimmy
    Zhao, Zhi-Qing
    MOLECULES, 2023, 28 (03):
  • [5] Vagal and Brain GLP-1 Receptor Populations Mediate the Hypophagic Effects of Peripheral GLP-1 Receptor Agonists, Liraglutide and Exendin-4
    Kanoski, Scott E.
    Fortin, Samantha
    Arnold, Myrtha
    Hayes, Matthew R.
    Grill, Harvey
    OBESITY, 2011, 19 : S48 - S48
  • [6] Cardiovascular safety and GLP-1 receptor agonists
    Carty, David M.
    Drummond, Russell
    Fisher, Miles
    PRACTICAL DIABETES, 2013, 30 (06) : 242 - 245
  • [7] GLP-1 receptor agonists and cardiovascular safety
    Huang, Yu-Yao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S20 - S20
  • [8] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [9] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [10] GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
    Valeria Guglielmi
    Paolo Sbraccia
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2017, 22 : 231 - 240
12345